| Views | |
|---|---|
| GD2-directed bispecific trifunctional antibody outperforms dinutuximab beta in a murine model for aggressive metastasized neuroblastoma | 223 |
| April 2025 | May 2025 | June 2025 | July 2025 | August 2025 | September 2025 | October 2025 | |
|---|---|---|---|---|---|---|---|
| GD2-directed bispecific trifunctional antibody outperforms dinutuximab beta in a murine model for aggressive metastasized neuroblastoma | 18 | 10 | 4 | 12 | 2 | 12 | 12 |
| Views | |
|---|---|
| 2021_Zirngibl_etal.pdf | 256 |
